Management of metabolic syndrome and reduction in body weight in type II diabetic mice by inhibiting glycosphingolipid synthesis
- 24 February 2020
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 525 (2), 455-461
- https://doi.org/10.1016/j.bbrc.2020.02.104
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (PO1HL1-0153PO1HL-0153, 3PO1HL107153-03S1)
- To Enhance Development Corporation
- - Maryland Innovation Initiative award
This publication has 33 references indexed in Scilit:
- Use of a Glycolipid Inhibitor to Ameliorate Renal Cancer in a Mouse ModelPLOS ONE, 2013
- Inhibition of Glycosphingolipid Synthesis Induces a Profound Reduction of Plasma Cholesterol and Inhibits Atherosclerosis Development in APOE*3 Leiden and Low-Density Lipoprotein Receptor−/− MiceArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- ApoE4 disrupts sterol and sphingolipid metabolism in Alzheimer's but not normal brainNeurobiology of Aging, 2009
- The Yin and Yang of lactosylceramide metabolism: Implications in cell functionBiochimica et Biophysica Acta (BBA) - General Subjects, 2008
- Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin SensitivityDiabetes, 2007
- Inhibiting Glycosphingolipid Synthesis Improves Glycemic Control and Insulin Sensitivity in Animal Models of Type 2 DiabetesDiabetes, 2007
- Glycosphingolipid Accumulation Inhibits Cholesterol Efflux via the ABCA1/Apolipoprotein A-I PathwayOnline Journal of Public Health Informatics, 2005
- A review of the epidemiological evidence for the ‘antioxidant hypothesis’Public Health Nutrition, 2004
- Glycosphingolipid Accumulation in the Aortic Wall Is Another Feature of Human AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATIONCanadian Journal of Biochemistry and Physiology, 1959